Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Cancer Immunotherapy and Biomarkers

82 ta ish

  1. 30P Cemiplimab in treatment of metastatic and recurrent cervical cancer

    F.M. Djuraev, A.S. Abdujapparov

    MaqolaCancer Immunotherapy and BiomarkersESMO Open20240 iqtibos
    ABI

  2. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

    Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7

    Sharh maqolaCAR-T cell therapy researchCritical Reviews in Oncology/Hematology20240 iqtibos
    ABI

  3. Obacunone potentiated PD-1 immunotherapy in pancreatic cancer by mediating CD36

    Chun‐Yan Sang, Jia-Rong Liu, Yi-Dan Zheng +6

    MaqolaCancer Immunotherapy and BiomarkersEuropean Journal of Pharmacology20250 iqtibos
    ABI

  4. Current trends on immunotherapy for oncology

    Neya Kavya Chander, A Prashannalakshmi, Phanish Chandra Ravi +4

    MaqolaImmunotherapy and Immune ResponsesBioinformation20250 iqtibos
    ABI

  5. Invisible influencers: the tumor microbiome’s impact on immunotherapy in colorectal cancer (CRC)

    Thabit Moath Omar, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +8

    MaqolaCancer Research and TreatmentsExpert Review of Anticancer Therapy20250 iqtibos
    ABI

  6. DECIPHERING THE IMMUNE LANDSCAPE OF OVARIAN CANCER: AN IN-DEPTH ANALYSIS OF IGCH CD4+, CD8+, AND PD-L1 IN TUMOR MICROENVIRONMENT AND THEIR THERAPEUTIC IMPLICATIONS

    Firdavs Ulmasov, Dilfuzakhon Mamarasulova, Bustonoy Esankulova

    MaqolaImmune Cell Function and InteractionMedical science of Uzbekistan20250 iqtibos
    ABI

  7. The role of macrophages in cancer progression: M1, M2 subtypes, and their impact on tumor microenvironment

    Mamatova Irodakhon Yusupovna, Ibrohimjon Rahmonovich Asqarov, Gulruxan Jurayevna Ulug’bekova

    MaqolaImmune cells in cancerInternational Journal of Innovative Research and Scientific Studies20250 iqtibos
    ABI

  8. Immuno-oncology approaches to overcome T cell exhaustion in melanoma

    Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Mohammad Y. Alshahrani, Muzdalifa Mejbel Fedwi +7

    MaqolaCancer Immunotherapy and BiomarkersSeminars in Oncology20250 iqtibos
    ABI

  9. THE ROLE OF THE TUMOR MICROENVIRONMENT IN THE TREATMENT AND PROGNOSIS OF BREAST CANCER

    Rakhimova, Farangiz

    MaqolaImmune cells in cancerZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  10. THE ROLE OF THE TUMOR MICROENVIRONMENT IN THE TREATMENT AND PROGNOSIS OF BREAST CANCER

    Rakhimova, Farangiz

    MaqolaImmune cells in cancerZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  11. Correction: Sepsis-related immune signature C3 in endometrial carcinoma: implications for prognosis, tumor progression through bioinformatics and experimental validation

    Kulsoom, Wajahat Ali, Saleem Ahmad +8

    BoshqaCancer Immunotherapy and BiomarkersMolecular Biology Reports20250 iqtibos
    ABI

  12. Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

    Qianqian Huang, Fan Tong, Jiantao Chen +5

    Sharh maqolaNanoplatforms for cancer theranosticsAdvanced Science20250 iqtibos
    ABI

  13. Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

    Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi +10

    Sharh maqolaT-cell and B-cell ImmunologyImmunological Investigations20250 iqtibos
    ABI

  14. New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK

    Saade Abdalkareem Jasim, Harikumar Pallathadka, G. V. Sivaprasad +7

    Sharh maqolaCAR-T cell therapy researchFunctional & Integrative Genomics20250 iqtibos
    ABI

  15. Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies

    Omer Qutaiba B. Allela, Ali Fawzi Al-Hussainy, Gaurav Sanghvi +9

    Sharh maqolaCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 iqtibos
    ABI

  16. SLAMF8 (BLAME) as a novel immune checkpoint: Implications for inflammation, autoimmunity, and oncology

    Ahmed Husseni, Farag M. A. Altalbawy, Irwanjot Kaur +7

    Sharh maqolaImmune Cell Function and InteractionPathology - Research and Practice20250 iqtibos
    ABI

  17. A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors

    Saade Abdalkareem Jasim, Jitendra Gupta, Subasini Uthirapathy +7

    Sharh maqolaCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 iqtibos
    ABI

  18. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

    Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

    MaqolaCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 iqtibos
    ABI

  19. THE MICROBIOME FACTOR IN ONCOLOGY: ENHANCING DRUG EFFICACY AND REDUCING ADVERSE EFFECTS THROUGH MICROBIOTECHNOLOGICAL MODULATION

    Najmiddin Xabibullayev, Hakim To'ychiyev

    MaqolaGut microbiota and healthOpen MIND20260 iqtibos
    ABI

  20. THE MICROBIOME FACTOR IN ONCOLOGY: ENHANCING DRUG EFFICACY AND REDUCING ADVERSE EFFECTS THROUGH MICROBIOTECHNOLOGICAL MODULATION

    Najmiddin Xabibullayev, Hakim To'ychiyev

    MaqolaGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  21. Nervous and immune system crosstalk shapes cancer progression and treatment response

    Mustafa TArdah, Raghda AliBakr, H. Malathi +6

    MaqolaCancer, Stress, Anesthesia, and Immune ResponseDiscover Oncology20260 iqtibos
    ABI

  22. Integrating histopathology and immune marker analysis for machine learning-based colorectal cancer prognostics

    Mohamed J. Saadh, Tamara Nazar Saeed, Karar H. Alfarttoosi +10

    MaqolaAI in cancer detectionDiagnostic Pathology20260 iqtibos
    ABI

  23. Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments

    Qamar Abuhassan, Ali M Atoom, M.M. Rekha +5

    MaqolaPsoriasis: Treatment and PathogenesisHuman Immunology20260 iqtibos
    ABI

  24. Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunity

    Chou-Yi Hsu, Ahmed Hjazi, Muath Suliman +7

    MaqolaCancer Immunotherapy and BiomarkersJournal of Pharmacology and Experimental Therapeutics20260 iqtibos
    ABI

  25. Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy

    Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

    MaqolaCancer Immunotherapy and BiomarkersAnnals of Hematology20260 iqtibos
    ABI